Cryptococcosis in human immunodeficiency virus-infected children

被引:55
作者
Gonzalez, CE [1 ]
Shetty, D [1 ]
Lewis, LL [1 ]
Mueller, BU [1 ]
Pizzo, PA [1 ]
Walsh, TJ [1 ]
机构
[1] NCI,INFECT DIS SECT,PEDIAT BRANCH,BETHESDA,MD 20892
关键词
pediatric acquired immunodeficiency syndrome; cryptococcosis; amphotericin B; flucytosine;
D O I
10.1097/00006454-199609000-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Cryptococcosis is a common opportunistic infection in adults with AIDS. Few cases of cryptococcosis complicating pediatric AIDS have been reported. To our knowledge there are no studies that describe the epidemiology, clinical manifestations and outcome of cryptococcosis in a large population of HIV-infected children, Methods. We identified the cases of cryptococcosis through a retrospective review of the hospital records of the 473 HIV-infected children prospectively monitored in the Pediatric Branch of the National Cancer Institute during the 8 years from 1987 to 1995. Results. Pour (0.85%) patients developed cryptococcosis during the study period. All patients had profound depression of the absolute CD4 counts, a history of previous opportunistic infections, and onset of cryptococcosis in the second decade of life. Cryptococcosis developed as a disseminated infection or a localized process of the lungs. Intermittent fever was the most common presenting manifestation. Serum cryptococcal antigen was positive in all patients and gradually declined after the institution of the antifungal therapy. All patients were treated with amphotericin B with or without flucytosine as initial therapy. Suppressive therapy consisted of fluconazole with or without flucytosine, There were no deaths due to Cryptococcus neoformans. Conclusions. Cryptococcosis is an infrequent yet treatable opportunistic infection of advanced pediatric AIDS that may present with subtle manifestations and warrants careful consideration in the evaluation of febrile HIV-infected children.
引用
收藏
页码:796 / 800
页数:5
相关论文
共 21 条
[1]  
ALLENDE M, 1992, PEDIATR INFECT DIS J, V12, P2400
[2]   COMPARISON OF AMPHOTERICIN-B ALONE AND COMBINED WITH FLUCYTOSINE IN THE TREATMENT OF CRYPTOCCAL MENINGITIS [J].
BENNETT, JE ;
DISMUKES, WE ;
DUMA, RJ ;
MEDOFF, G ;
SANDE, MA ;
GALLIS, H ;
LEONARD, J ;
FIELDS, BT ;
BRADSHAW, M ;
HAYWOOD, H ;
MCGEE, ZA ;
CATE, TR ;
COBBS, CG ;
WARNER, JF ;
ALLING, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03) :126-131
[3]   EVOLVING ROLE OF FLUCYTOSINE IN IMMUNOCOMPROMISED PATIENTS - NEW INSIGHTS INTO SAFETY, PHARMACOKINETICS, AND ANTIFUNGAL THERAPY [J].
FRANCIS, P ;
WALSH, TJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :1003-1018
[4]  
GERBEAUX J, 1975, ANN MED INTERNE, V126, P615
[5]   PERFORMANCE OF CRYPTOCOCCUS ANTIGEN LATEX AGGLUTINATION KITS ON SERUM AND CEREBROSPINAL-FLUID SPECIMENS OF AIDS PATIENTS BEFORE AND AFTER PRONASE TREATMENT [J].
HAMILTON, JR ;
NOBLE, A ;
DENNING, DW ;
STEVENS, DA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :333-339
[6]   CUTANEOUS CRYPTOCOCCOSIS MIMICKING MOLLUSCUM CONTAGIOSUM IN A HEMOPHILIAC WITH AIDS [J].
JIMENEZACOSTA, F ;
CASADO, M ;
BORBUJO, J ;
SOTOMELO, J ;
VIGUER, JM ;
SANJURJO, MJ .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (06) :446-450
[7]   FLUCONAZOLE COMPARED WITH AMPHOTERICIN-B PLUS FLUCYTOSINE FOR CRYPTOCOCCAL MENINGITIS IN AIDS - A RANDOMIZED TRIAL [J].
LARSEN, RA ;
LEAL, MAE ;
CHAN, LS .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (03) :183-187
[8]   FLUCONAZOLE COMBINED WITH FLUCYTOSINE FOR TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS [J].
LARSEN, RA ;
BOZZETTE, SA ;
JONES, BE ;
HAGHIGHAT, D ;
LEAL, MA ;
FORTHAL, D ;
BAUER, M ;
TILLES, JG ;
MCCUTCHAN, JA ;
LEEDOM, JM .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (04) :741-745
[9]   EXTRAPULMONARY CRYPTOCOCCOSIS IN CHILDREN WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
LEGGIADRO, RJ ;
KLINE, MW ;
HUGHES, WT .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (09) :658-662
[10]   EXTRAPULMONARY CRYPTOCOCCOSIS IN IMMUNOCOMPROMISED INFANTS AND CHILDREN [J].
LEGGIADRO, RJ ;
BARRETT, FF ;
HUGHES, WT .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (01) :43-47